rdf:type |
|
lifeskim:mentions |
umls-concept:C0007589,
umls-concept:C0007600,
umls-concept:C0142812,
umls-concept:C0242643,
umls-concept:C0332293,
umls-concept:C0441889,
umls-concept:C0442805,
umls-concept:C0600432,
umls-concept:C1511938,
umls-concept:C1515670,
umls-concept:C1516960
|
pubmed:issue |
12
|
pubmed:dateCreated |
1991-3-6
|
pubmed:abstractText |
We examined the effect of hemin, sodium butyrate and mitomycin C on levels of P-glycoprotein mRNA in human myelogenous K562 cells by northern blot analysis. After treatment with sodium butyrate a dose-dependent increase of P-glycoprotein mRNA expression was observed in the adriamycin-resistant K562 and vincristine-resistant K562 lines. With 10 mM sodium butyrate, the level of P-glycoprotein mRNA reached 20 times that of control adriamycin-resistant K562 and with 30 mM sodium butyrate, it exceeded 5 times that of control vincristine-resistant K562. In contrast, hemin and mitomycin C had almost no effect on P-glycoprotein mRNA. In this experiment, since expression of P-glycoprotein mRNA was not necessarily accompanied with induction of erythroid differentiation, the increased amount of P-glycoprotein mRNA is unlikely to be a result of differentiation.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Butyric Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Butyric Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Hemin,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycin,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycins,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0910-5050
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1214-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1980493-Blotting, Northern,
pubmed-meshheading:1980493-Butyric Acid,
pubmed-meshheading:1980493-Butyric Acids,
pubmed-meshheading:1980493-Cell Differentiation,
pubmed-meshheading:1980493-Cell Line,
pubmed-meshheading:1980493-Doxorubicin,
pubmed-meshheading:1980493-Drug Resistance,
pubmed-meshheading:1980493-Gene Expression,
pubmed-meshheading:1980493-Hemin,
pubmed-meshheading:1980493-Humans,
pubmed-meshheading:1980493-Membrane Glycoproteins,
pubmed-meshheading:1980493-Mitomycin,
pubmed-meshheading:1980493-Mitomycins,
pubmed-meshheading:1980493-P-Glycoprotein,
pubmed-meshheading:1980493-RNA, Messenger,
pubmed-meshheading:1980493-Vincristine
|
pubmed:year |
1990
|
pubmed:articleTitle |
Increase in the level of P-glycoprotein mRNA expression in multidrug-resistant K562 cell lines treated with sodium butyrate is not accompanied with erythroid differentiation.
|
pubmed:affiliation |
Department of Clinical Cancer Chemotherapy, Tohoku University, Sendai.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|